
Multiple Sclerosis’ Heterogeneity
Multiple sclerosis (MS) is a highly heterogeneous disease. Patients respond differently to medications and have disease prognoses that vary greatly. The new Clinical Research Priority Program (CRPP) PrecisionMS looks at how therapies can be adapted […]